These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9156932)

  • 1. [Tissue plasminogen activator and inhibitor and the severity and extensiveness of vascular lesions in peripheral atherosclerosis of the legs].
    Rość D; Zekanowska E; Hryncewicz W; Cwiklińska-Jurkowska M; Jurkowski P; Kotschy M
    Pol Merkur Lekarski; 1996 Oct; 1(4):235-7. PubMed ID: 9156932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
    Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
    J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [t-PA activity, antigen and PAI-1 antigen levels in blood obtained from the patients with cerebral infarction].
    Yamada S; Yamada R; Ishii A; Ashikawa K; Nakamura M; Sasamata M; Watanabe S
    Rinsho Byori; 1990 Jul; 38(7):819-24. PubMed ID: 2119465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic markers of fibrinolytic responses of older persons to exercise training.
    Kulaputana O; Ghiu I; Phares DA; Ferrell RE; Macko RF; Goldberg AP; Hagberg JM
    Int J Sports Med; 2006 Aug; 27(8):617-22. PubMed ID: 16874588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tissue plasminogen activator antigen (t-PA Ag) and tissue plasminogen activator inhibitor (PAI-1) in the course of hemodialysis in patients with chronic renal failure].
    Piatkowska M; Kotschy M; Nartowicz E; Rajewski W
    Pol Merkur Lekarski; 1997 Jan; 2(9):205-7. PubMed ID: 10907030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical study of plasminogen activator activity in gingival tissue in dogs with gingivitis and periodontitis.
    Papadimitriou S; Tsantarliotou M; Makris G; Papaioannou N; Batzios Ch; Kokolis N; Dessiris A
    Res Vet Sci; 2006 Apr; 80(2):189-93. PubMed ID: 16098551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evidence of elevated soluble plasma thrombomodulin in atherosclerosis].
    Conri C; Seigneur M; Constans J; Mercier P; Baste JC; Dufourcq P; Boisseau MR
    J Mal Vasc; 1993; 18(2):112-8. PubMed ID: 8394402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
    Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
    Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
    Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S
    Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
    Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.
    Chandler WL; Velan T
    Thromb Res; 2003; 112(3):185-92. PubMed ID: 14967416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor].
    Giedrojć J; Stankiewicz A; Walkowiak M; Galar M; Bielawiec M
    Klin Oczna; 1996; 98(4):283-5. PubMed ID: 9463119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation.
    Crookston KP; Marsh CL; Chandler WL
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):79-88. PubMed ID: 10691102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.